ATE328881T1 - Tetrahydropyranderivate und ihre verwendung als therapeutika - Google Patents

Tetrahydropyranderivate und ihre verwendung als therapeutika

Info

Publication number
ATE328881T1
ATE328881T1 AT02755343T AT02755343T ATE328881T1 AT E328881 T1 ATE328881 T1 AT E328881T1 AT 02755343 T AT02755343 T AT 02755343T AT 02755343 T AT02755343 T AT 02755343T AT E328881 T1 ATE328881 T1 AT E328881T1
Authority
AT
Austria
Prior art keywords
sup
sub
therapeutics
replaced
hydrogen atoms
Prior art date
Application number
AT02755343T
Other languages
English (en)
Inventor
Pineiro Jose Luis Castro
Duncan Edward Shaw
Brian John Williams
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Application granted granted Critical
Publication of ATE328881T1 publication Critical patent/ATE328881T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
AT02755343T 2001-09-10 2002-09-06 Tetrahydropyranderivate und ihre verwendung als therapeutika ATE328881T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0121874.2A GB0121874D0 (en) 2001-09-10 2001-09-10 Therapeutic agents

Publications (1)

Publication Number Publication Date
ATE328881T1 true ATE328881T1 (de) 2006-06-15

Family

ID=9921835

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02755343T ATE328881T1 (de) 2001-09-10 2002-09-06 Tetrahydropyranderivate und ihre verwendung als therapeutika

Country Status (17)

Country Link
US (1) US7265110B2 (de)
EP (1) EP1427723B1 (de)
JP (1) JP2005506329A (de)
KR (1) KR20040045435A (de)
CN (1) CN1578778A (de)
AT (1) ATE328881T1 (de)
BR (1) BR0212454A (de)
CA (1) CA2459464A1 (de)
DE (1) DE60212153T2 (de)
ES (1) ES2263803T3 (de)
GB (1) GB0121874D0 (de)
IL (1) IL160785A0 (de)
MX (1) MXPA04002295A (de)
NO (1) NO20041431L (de)
PL (1) PL368208A1 (de)
RU (1) RU2004110950A (de)
WO (1) WO2003022839A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0121874D0 (en) 2001-09-10 2001-10-31 Merck Sharp & Dohme Therapeutic agents
GB0217068D0 (en) * 2002-07-23 2002-08-28 Merck Sharp & Dohme Therapeutic agents
US7393858B2 (en) * 2003-03-07 2008-07-01 Merck Sharp & Dohme Ltd. Tetrahydropyran compounds as tachykinin antagonists
US11773127B2 (en) * 2017-11-08 2023-10-03 Washington University Compounds and methods for treating bacterial infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2257964A1 (en) * 1996-06-21 1997-12-31 Merck Sharp & Dohme Limited Spiro-piperidine derivatives and their use as therapeutic agents
CO5150225A1 (es) * 1999-03-19 2002-04-29 Merck Sharp & Dohme Derivados del tetrahidropirano y su uso como agentes terapeuticos
GB0020721D0 (en) * 2000-08-22 2000-10-11 Merck Sharp & Dohme Therapeutic agents
GB0121874D0 (en) 2001-09-10 2001-10-31 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
US7265110B2 (en) 2007-09-04
IL160785A0 (en) 2004-08-31
NO20041431L (no) 2004-06-01
KR20040045435A (ko) 2004-06-01
CN1578778A (zh) 2005-02-09
PL368208A1 (en) 2005-03-21
EP1427723B1 (de) 2006-06-07
ES2263803T3 (es) 2006-12-16
DE60212153D1 (de) 2006-07-20
JP2005506329A (ja) 2005-03-03
EP1427723A1 (de) 2004-06-16
WO2003022839A1 (en) 2003-03-20
GB0121874D0 (en) 2001-10-31
BR0212454A (pt) 2004-10-19
CA2459464A1 (en) 2003-03-20
RU2004110950A (ru) 2005-04-10
MXPA04002295A (es) 2004-06-18
US20040254184A1 (en) 2004-12-16
DE60212153T2 (de) 2007-05-24

Similar Documents

Publication Publication Date Title
NO20083114L (no) Polysykliske indazolderivater som er ERK-inhibitorer
SG159380A1 (en) Heteroaryl compounds useful as inhibitors of gsk-3
ATE376547T1 (de) Derivate des indol-typs als p38 kinase inhibitoren
HK1068136A1 (en) Muscarinic antagonists
EA200601830A1 (ru) Ортозамещённые арильные или гетероарильные амидные соединения
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
IS8502A (is) Azatvíhringja heteróhringir sem kannabínóíð-viðtakastillar
AR068813A1 (es) Derivados de pirazol sustituidos como antagonistas del receptor de androgenos (ar), un agente farmaceutico que los comprende y su uso en el tratamiento del cancer de prostata
ATE253545T1 (de) Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren
BRPI0409938A (pt) derivados de azetidinacarboxamida e seu uso em terapia
DK1765816T3 (da) Substituerede 1-propinylpiperaziner med affinitet for MGluR5-receptoren til behandling af smertetilstande
TW200621786A (en) Condensed pyrazole derivatives, their preparation and application in therapeutics
MX2009002229A (es) Benzotriazoles como moduladores de cinasas.
ATE537830T1 (de) Nicotinamid derivate und ihre verwendung als therapeutika
NO20052182L (no) Nye forbindelser
MXPA06013387A (es) Nuevos derivados de piridazinona como inhibidores de cdk2.
MX2009003073A (es) Derivado de 2-piridincarboxamida que tiene efecto activador de gk.
ATE374190T1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
ATE374773T1 (de) Polycyclische verbindungen als potenten alpha2- adrenoceptor antagonisten
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
GB0314967D0 (en) Piperazine derivatives
TW200420292A (en) Benzofuran derivative
WO2003103590A3 (en) HETEROBICYCLIC P38 (HALO-BENZO CARBONYL) KINASE INHIBITORS
ATE328881T1 (de) Tetrahydropyranderivate und ihre verwendung als therapeutika
DE602004018811D1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties